Jugular foramen schwannoma: A rare tumor treated by stereotactic radiosurgery

Jugular foramen schwannomas (JFS) are rare benign tumors located in the jugular foramen. They can present with various symptoms depending on the extent of involvement of the tumor such as hearing loss, tinnitus, headache, and ataxia. Surgical resection has been considered as the primary treatment option for JFS. Stereotactic radiosurgery (SRS) offers an equally good treatment in patients with small and residual tumors after surgery with the advantage of being non-invasive with minimal complication rates. Herein, we present a rare case of JFS treated by SRS in our institution.

Artificial intelligence in healthcare: Should it be included in the medical curriculum? A students’ perspective

The application of artificial intelligence (AI) in healthcare has increased due to rapid digitization and integration of computer science in all fields. However, the outcome in relation to patient treatment and healthcare delivery is not that visible. The reasons could be non-availability of data, lack of computerization and financial constraints. Besides this, the lack of appropriate teaching at undergraduate level about AI and its medical applications could be an obstacle. Including AI in medical school curriculum and collaboration with faculties of computer science can augment the knowledge of medical students about AI at the graduate level for better application in the real world. This will help the medical profession to prepare their younger fraternity for the future in AI.

Publications by radiation oncologists from India: a brief survey.

BACKGROUND: In India, the past three decades have seen a rapid growth of radiotherapy as a specialty. Has this led to an improvement in the quality and quantity of publications related to radiotherapy? To study this we evaluated publications by radiation oncologists of India from 1992 to 1998. METHODS: Twelve journals (5 Indian and 7 international) indexed in PubMed which publish radiation oncology-related papers were surveyed between January 1992 and June 1998 in terms of the content of the papers and institutional affiliation of the radiation oncologists from India. Of a total of 14 436 papers published during this period, 2562 were in Indian and 11 874 in international journals. We also evaluated the contents of the publications. RESULTS: The contribution of radiation oncologists from India accounted for 109 papers (0.75%)-64 (2.5%) and 45 (0.4%) in Indian and international journals, respectively. Three institutions from India contributed 52 of the 109 published papers (47.7%). Articles on radiation oncology from India constituted less than 1% of the surveyed publications. Also, publications with a 'good' scientific content formed a small part of the Indian radiotherapy publications. CONCLUSIONS: Collaborative studies, inter-institutional trials and randomized clinical trials relating to key oncological problems in India need to be carried out to establish consensus and guidelines at a national level.

Sentinel lymph node biopsy, axillary dissection and breast cancer: radiation oncologist's viewpoint.

Sentinel lymph node (SLN) identification and biopsy in breast cancer have been carried out successfully since the early 1990s. In early-stage breast cancer, the negative predictive value of a SLN biopsy is as high as 93%-100%. With a negative SLN, no axillary treatment would be required and the breast can be treated by tangential radiation fields. Currently, for a patient with a positive SLN, axillary dissection is recommended. Axillary irradiation can replace surgery with a low risk of recurrence (< 7%). The modern practice of radiotherapy, delivering a dose of 50 Gy to the axilla, has a low rate of late morbidity. Hence, it is now time to plan clinical trials comparing axillary irradiation with axillary dissection in SLN-positive, early-stage breast cancer. These approaches to the axilla, guided by the status of the SLN can reduce arm problems in women with breast cancer and improve their quality of life. Just as the treatment of the primary breast tumour has changed from Halstedian mastectomy to conservation surgery combined with breast irradiation, SLN biopsy may allow a move away from surgical axillary clearance and the associated morbidity in the future.